22 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
-Terrorism Laws.
Section 3.23. Broker’s Fees.
Section 3.24. Data Privacy and Information Security.
Article IV. REPRESENTATIONS AND WARRANTIES … with this Agreement.
Section 3.24.Data Privacy and Information Security.
(a)The Company and its Subsidiaries maintain industry appropriate data security policies
8-K
EX-1.1
rirgbbh ki
16 Jul 20
Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
5:15pm
10-K
uwhb1u5ulp ysy9t
26 Feb 20
Annual report
4:53pm
424B4
2f3x8bsb0w2pdtldd
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
a6zjli818i3jk9
9 Jan 20
Draft registration statement
12:00am
424B4
l2k7tbxhvmg7siba4jvn
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
tx0cg8t dpang92
30 May 19
IPO registration
5:20pm
S-1
EX-10.2
k4ryr0 klddntu
30 May 19
IPO registration
5:20pm
DRS/A
cun55gs3agkah0t
8 May 19
Draft registration statement (amended)
12:00am